About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Tickers CLNN
Tags Penny Stocks Biotech Briefs
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
Tickers BBIO
Tags Benzinga Biotech Briefs
From Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
Tickers SRRK
Tags Spinal Muscular Atrophy General Phase 2 Trial
From Benzinga
Why Sanofi Shares Are Trading Lower Today
Tickers SNY
Tags News Phase 2 Trial why it's moving
From Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
Tickers MRNA
Tags Phase 2 Trial News Market News
From Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
Tickers IVA
Tags Biotech Briefs Benzinga
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags Market News News Phase 2 Trial
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Tickers AMGN
Tags Market News AMGN Pancreatic Cancer
From Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
Tickers ENDP IBRX MRK
Tags IBRX MRK General
From Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
Tickers BTAI MRK
Tags Benzinga Briefs Biotech
From Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags Age/Related Macular Degeneration Briefs Biotech
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags Market News News Phase 2 Trial
From Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
Tickers FDMT
Tags Fabry disease Phase 1 Trial General
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags Market News Phase 2 Trial News
From Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
Tickers NLSP
Tags Benzinga Penny Stocks Biotech
From Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
Tickers PFE VALN
Tags Market News PFE Phase 2 Trial
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
Tickers ALT
Tags Market News Phase 2 Trial FDA
From Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Tickers JNJ KLDO
Tags FDA Phase 2 Trial News
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Phase 1 Trial TSHA General
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags General Phase 1 Trial Market News
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags News TYME Phase 3 Trial
From Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
Tickers WVE
Tags Phase 1 Trial General Contracts
From Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
Tickers IMRA
Tags Market News News Phase 2 Trial
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags Health Care FBIO MBIO
From Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
Tickers ETNB
Tags Benzinga General ETNB
From Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
Tickers TNGX
Tags Benzinga Briefs Biotech
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags Briefs Biotech SABS
From Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
Tickers MDWD
Tags Briefs Penny Stocks MDWD
From Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
Tickers MRTX
Tags News Phase 2 Trial MRTX
From Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
Tickers PRVB
Tags Phase 2 Trial News Systemic Lupus Erythematosus
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.